PRZOOM - /newswire/ - Winston-Salem, NC, United States, 2011/09/21 - SmallCapReview.com, A leading site for news and information on small caps, penny stocks and microcaps is adding Allezoe Medical (ALZM) to its list of stocks "On the Radar".

Allezoe Medical (ALZM) a biomedical company that develops, patents, and sells portable hypothermic, oxygenated preservation, and transport technology for human organs. It designs and develops the LifeCradle, which consists of a portable platform and an organ specific disposable set. The company's primary product, LifeCradle HR Cardiac Perfusion System, perfuses and feeds a heart through a circulating, oxygenated, and hypothermic nutrient solution to preserve and maintain the organ. It is also developing proprietary perfusion solutions for use in the LifeCradle devices.

ALZM is in the process of acquiring a company that diagnosis and and has treatments for Human Papillomavirus (HPV), Bovine Papillomavirus (BPV), and potentially cervical cancer. Human Papillomavirus (HPV) is the most common sexually transmitted infection. Approximately 20 million Americans are infected with HPV and it is expected that 5.5 million will contract the HPV through sexual contact each year.

Allezoe is also in stages of discussions to acquire a number of organizations including: A company that has state-of-the-art implant technologies for spinal surgery. This company’s technology aims to facilitate spinal surgery and improve post-surgery quality of life for patients. As the senior population lives longer, and more opt for surgery to ease back pain, ALZM hopes to support options that offer them maximum comfort.A South Florida-based clinical trial research company. Clinical trials are where great medical advancements are made, proven, and promoted to the next level.

ALZM Investor Highlights

Announced that it has agreed to acquire patent pending technology that would enable healthcare providers to "see and treat" Papillomavirus (HPV), the most common sexually transmitted infection and a cause of cervical cancer, In addition to offering easy, affordable, and on-the-spot HPV diagnosis, the technology offers an important alternative to the HPV vaccine.

Allezoe has acquired the pending patent application and all related intellectual property as well as the existing prototype models of the device. Allezoe plans to form a new wholly-owned subsidiary to complete the development of the device, obtain the required regulatory approvals and clearances, and begin marketing the device and technology.

Organ Transport Systems, Inc. its wholly-owned subsidiary, has expanded research on its LifeCradle HR device for donor heart preservation to include a new collaboration with Duke University Medical Center ("Duke").

Current statistics show that only 27% of donated hearts and only 9% of donated lungs actually can be transplanted for various reasons, many of which OTS addresses with its medical devices. The OTS LifeCradle technology has already been shown in pre-clinical studies to significantly increase preservation time and improve the condition of transplanted animal hearts compared with the current systems in use.

Allezoe is in various stages of discussions to acquire a company that has state-of-the-art implant technologies for spinal surgery and a clinical trial research company.

Features available at SmallCapReview.com include in-depth profiles of select Small-Cap/Penny Stocks as well as the most comprehensive and up to date news available on the small-cap market.

No investor should assume that reliance on the views, opinions or recommendations contained herein will produce profitable results. Nothing within our site should be construed as an offer or solicitation to buy or sell products or securities. The companies we profile may lack an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. SmallCapReview.com has been compensated five thousand dollars by a third party AWT for its services with regards to Allezoe Medical.

Copyright SmallCapReview. SmallCapReview.com is a leading site for news on small-caps, penny stocks and microcaps. A news service of SCR, 2312 Healy Dr., Winston-Salem, NC 27107. SmallCapReview has built a loyal opt-in following for their investor products by providing a newsletter at no cost, sent to subscribers, highlighting select stocks in play, to register visit smallcapreview.com/.

Agency / Source: SmallCapReview

Availability: All Regions (Including Int'l)

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

Distribution / Indexing: [+]